For: | Huang BB, Han LC, Liu GF, Lv XD, Gu GL, Li SQ, Chen L, Wang HQ, Zhan LL, Lv XP. Infliximab is effective in the treatment of ulcerative colitis with dermatomyositis: A case report. World J Gastroenterol 2020; 26(46): 7425-7435 [PMID: PMC7739156 DOI: 10.3748/wjg.v26.i46.7425] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i46/7425.htm |
Number | Citing Articles |
1 |
|
2 |
Kareem G Elhage, Raymond Zhao, Mio Nakamura. Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature. Clinical, Cosmetic and Investigational Dermatology 2022; : 1815 doi: 10.2147/CCID.S382628
|
3 |
The treatment of inflammatory bowel disease with monoclonal antibodies in Asia. Biomedicine & Pharmacotherapy 2023; 157: 114081 doi: 10.1016/j.biopha.2022.114081
|
4 |
Talwinder K Nagi, Yousra Gheit, Oscar L Hernandez, Zoilo K Suarez, Charles Vallejo, Muhammad Adnan Haider, Touqir Zahra. Myositis as an Extraintestinal Manifestation of Ulcerative Colitis: A Case Report and Literature Review. Cureus 2023; doi: 10.7759/cureus.42336
|
5 |
Michel Ntiri, Alessandra Haskin, Eve J. Lowenstein. Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa. JAAD Case Reports 2022; 29: 76 doi: 10.1016/j.jdcr.2022.08.048
|
6 |
Silvia Grazzini, Chiara Rizzo, Edoardo Conticini, Roberto D'Alessandro, Lidia La Barbera, Miriana D'Alessandro, Paolo Falsetti, Elena Bargagli, Giuliana Guggino, Luca Cantarini, Bruno Frediani. The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review. Autoimmunity Reviews 2023; 22(2): 103264 doi: 10.1016/j.autrev.2022.103264
|